GM16469
LCL from B-Lymphocyte
Description:
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC
XPC COMPLEX SUBUNIT, DNA DAMAGE RECOGNITION AND REPAIR FACTOR; XPC
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Nucleotide and Nucleic Acid Metabolism |
Class |
Repair Defective and Chromosomal Instability Syndromes |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Family Member
|
3
|
Relation to Proband
|
father
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
XPC |
Chromosomal Location |
3p25 |
Allelic Variant 1 |
613208.0006; XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C |
Identified Mutation |
2-BP DEL, 669AT; Slor et al. [J. Invest. Derm. 115: 974-980 (2000)] reported
a homozygous A-T deletion of 2 bases (669-670) in exon 5 of the XPC gene
in two Israeli sibs with severe xeroderma pigmentosum symptoms. The
mutation, which was expected to encode a truncated xeroderma
pigmentosumcomplementation group C protein, resulted in a new termination
site 10 codons downstream. Cultured skin fibroblasts from both patients
showed reductions in postultraviolet survival (11% of normal), unscheduled
DNA synthesis (10% of normal), global genome DNA repair (15% of normal),
and plasmid host cell reactivation (5% of normal). Transcription-coupled
DNA repair was normal, however. Northern blot analysis revealed greatly
reduced xeroderma pigmentosum complementation group C mRNA. Sun
protection delayed the onset of skin cancer and prolonged life in the
second sib. |
Remarks |
XPH107BE; father of an affected child (GM16467); donor subject is heterozygous for a 2 bp deletion in exon 5 of the XPC gene (669_670delAT) resulting in premature termination 10 codons downstream (C223fsX233) |
Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB, Inui H, Emmert S, Imoto K, Muniz-Medina V, Baker CC, Digiovanna JJ, Schmidt D, Khadavi A, Metin A, Gozukara E, Slor H, Sarasin A, Kraemer KH, Reduced XPC DNA repair gene mRNA levels in clinically normal arents of xeroderma pigmentosum patients. Carcinogenesis27(1):84-94 2005 |
PubMed ID: 16081512 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|